Company
Headquarters: Taipei City, Taiwan
TW$3.06 Billion
TWD as of Jan. 1, 2024
US$99.6 Million
Company | Market Cap (USD) |
---|---|
Zoetis Inc. | $89.09 B |
MERCK Kommanditgesellschaft auf Aktien | $67.64 B |
Takeda Pharmaceutical Company Limited | $47.71 B |
Haleon plc | $38.90 B |
PPD, Inc. | $16.58 B |
Company | Market Cap (USD) |
---|---|
Lilly | $586.39 B |
UnitedHealth Group | $504.47 B |
Novo Nordisk | $461.52 B |
Johnson & Johnson | $387.50 B |
Merck | $296.51 B |
GeneFerm Biotechnology Co., Ltd. develops, manufactures, markets, and sells fermented products in Taiwan and internationally. The company offers a range of raw materials, such as fermented microbial, fungi, and fruits and vegetables products; probiotics; and herbal extracts and animal derived peptides and powders. It also provides ODM, as well as fermentation toll manufacturing services to companies for the development and manufacture of dietary supplements, functional foods, health food products, and various applications. The company was founded in 1999 and is based in Taipei City, Taiwan.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
GeneFerm Biotechnology Co. Ltd has the following listings and related stock indices.
Stock: TWSE: 1796 wb_incandescent